MedPath

Lomustine

Generic Name
Lomustine
Brand Names
Ceenu, Gleostine
Drug Type
Small Molecule
Chemical Formula
C9H16ClN3O2
CAS Number
13010-47-4
Unique Ingredient Identifier
7BRF0Z81KG

Overview

An alkylating agent of value against both hematologic malignancies and solid tumors.

Background

An alkylating agent of value against both hematologic malignancies and solid tumors.

Indication

For the treatment of primary and metastatic brain tumors as a component of combination chemotherapy in addition to appropriate surgical and/or radiotherapeutic procedures. Also used in combination with other agents as secondary therapy for the treatment of refractory or relapsed Hodgkin's disease.

Associated Conditions

  • Metastatic Brain Tumors
  • Primary Brain Neoplasm
  • Refractory Hodgkin Lymphoma

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath